General Information of DTT (ID: TTR01E9)

DTT Name Mannan-binding lectin serine protease-2 (MASP2) DTT Info
Gene Name MASP2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Narsoplimab DM5KD99 IgA nephropathy MF8Y Phase 3 [1]
OMS721 DMK6QBZ Atypical hemolytic uremic syndrome 3A10.Y Phase 3 [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy. J Clin Oncol. 2022 Aug 1;40(22):2447-2457.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)